Alembic Pharmaceuticals has received tentative approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Brexpiprazole Tablets, 0.25mg, 0.5mg ...

Sun Pharmaceutical Industries Ltd. 524715 shares advanced 1.66% to 967.30 Indian rupees Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P BSE ...

Acadia Pharmaceuticals Inc. (ACAD) said its newly approved treatment for Rett syndrome has an annual list price ranging from $575,000 to $595,000, according to a company spokesperson. The Food and ...

Sun Pharmaceutical Industries Ltd. 524715 shares inched down 0.16% to 954.20 Indian rupees Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P BSE ...

Pradeep Drug company, a Chennai based API manufacturer is merged with Sun Pharma. Plans are shared to set up a new research campus in Chennai, which is later dropped as a suitable site is found in ...

For years, the FDA has defended its efforts to intercept prescription drugs coming from abroad by mail as necessary to keep out dangerous opioids, including fentanyl. The pharmaceutical industry ...

Sun Pharma’s Yonsa (prostate cancer), a crucial product in its speciality portfolio, was approved as an NDA (New Drug Approval) under the 505(b)(2) pathway with clinical trials. The product has ...

Acquisition Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, to Sun Pharma's Global ... The U.S. Food and Drug Administration recently ...

The FDA accepted for review Sanofi SNY and partner ... were administered via subcutaneous injection. The NYSE ARCA Pharmaceutical Index declined 1.98% in the last five trading sessions.

Marksans Pharma shares gained nearly 2 percent on March 10 after the US health regulator gave its approval for the company's Famotidine tablets that work as acid reducer. Famotidine tablets are ...